-
A Comprehensive Review of Advances in Molecular Mechanisms and Targeted Therapies for the Specific Type of Cystic Lung Cancer
11 Feb 2025 15:06 GMT
… is the most neuroendocrine lung tumor, and it also … Lung cancers associated with cystic airspaces: CT features and pathologic correlation. Lung Cancer … -L1 expression in rare lung tumors. Pathol Oncol Res. … phase II study of sunitinib in recurrent and…
-
How Advanced Are Extracellular Vesicles in Renal Cell Carcinoma? For Diagnostic and Therapeutic Frontiers
06 Sep 2025 06:12 GMT
… to sensitive cells, propagating sunitinib resistance.
Developing new … target for both sunitinib-sensitive and sunitinib-resistant RCC.62 … of non-small-cell lung cancer cells via the KLF7… Combination of tipifarnib and sunitinib overcomes renal cell carcinoma …
-
Development of Diagnostic and Predictive Models for COPD Based on Anoikis Resistance
06 Sep 2025 06:12 GMT
… al. FAM188B downregulation sensitizes lung cancer cells to anoikis via EGFR … in non-small cell lung cancer. Cancer Sci. 2023; … resistance and EMT of lung cancer cells by modulating JAK2… promotes aerobic glycolysis and sunitinib resistance of clear cell …
-
Natural Products From Traditional Chinese Medicine: Potential Therapeutic Agents in Cancer Therapy-Induced Cardiotoxicity
02 Sep 2025 16:45 GMT
… , as well as lung cancer.134 Clinical records show … malignancies, including small-cell lung cancer, ovarian cancer, lymphoma, … kinase inhibitors (sorafenib and sunitinib) and proteasome inhibitors ( … in non‑small cell lung cancer (Review). Oncol Rep. …
-
Lenvatinib Plus Pembrolizumab Delays Tumor Progression in All Organs vs Sunitinib in Advanced RCC
05 Jun 2024 18:17 GMT
… in all organs vs sunitinib (Sutent) in patients with advanced … organ groups. In the lung tumor group, the median time … lenvatinib and pembrolizumab compared with sunitinib,” Viktor Grünwald, MD, … of patients who received sunitinib,” Grünwald said in conclusion …
-
The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study
02 Aug 2022 00:04 GMT
… to 15% of all lung cancers.1 SCLC comprises … chemotherapy for small cell lung cancer. Lung Cancer. 2006;52(3 … sunitinib in patients with relapsed or refractory small cell lung cancer. Lung Cancer … with relapsed small cell lung cancer. Lung Cancer. 2016;96:108– …
-
ZBED4: A Prognostic Biomarker and Therapeutic Target in Hepatocellular Carcinoma
20 Aug 2025 23:33 GMT
… that ZBED3 enhances lung cancer cell proliferation by … non-small cell lung cancer; SCLC, small cell lung cancer; CRC, colorectal … five targeted drugs (sorafenib, sunitinib, erlotinib, temsirolimus and … Zbed3 in regulating lung cancer cell proliferation. J …
-
Gastrointestinal Stromal Tumors Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approvals, MOA, ROA, NDA, IND, And Companies
21 Aug 2025 00:37 GMT
… with advanced non-small cell lung cancer (NSCLC).
On 14 August 2025 … Tumors Therapies such as Belzutifan, Sunitinib, CGT9486, DCC-3116, Ripretinib, … .
Gastrointestinal Stromal Tumors Therapies- Belzutifan, Sunitinib, CGT9486, DCC-3116, Ripretinib, UCB4594 …
-
Eight-Year Data for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Continue to Demonstrate Longest Survival Benefit vs. Sunitinib Reported in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
22 Jan 2024 22:20 GMT
… seeing sustained benefits over sunitinib in the primary … node positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non–small cell lung cancer, …
-
Ipsen: ASCO 2022: New Cabometyx® Data Show Encouraging Results in Monotherapy and in Combination Across Different Tumor Types Including Metastatic Non-Small Cell Lung Cancer
26 May 2022 21:17 GMT
… demonstrated deeper responses vs sunitinib. Regardless of treatment, … non-small cell lung cancer (NSCLC)
Lung cancer is one of … of lung cancer - NSCLC and SCLC (small cell lung cancer). … Organization: GLOBOCAN 2020 – Lung Cancer: Estimated cancer incidence, …